Related Experiment Videos
False-positive and false-negative rates in meconium drug testing
Clinical Chemistry
|November 1, 1995
Summary
Inefficient drug extraction from meconium can cause false negatives. Unconfirmed screening tests show a high false-positive rate, up to 43%, highlighting the need for accurate drug testing in newborns.
Area of Science:
- Forensic Toxicology
- Neonatal Drug Testing
Background:
- Meconium analysis is crucial for detecting in utero drug exposure.
- Inaccurate drug testing in meconium can lead to misdiagnosis and improper care for newborns.
Purpose of the Study:
- To evaluate the efficiency of different drug extraction methods from meconium.
- To determine the false-positive rate of unconfirmed screening tests for drugs in meconium.
Main Methods:
- Comparison of three published drug extraction procedures using validated meconium specimens.
- Confirmation of 535 screen-positive meconium specimens using gas chromatography-mass spectrometry (GC-MS).
Main Results:
- The tested extraction methods demonstrated significant variability in drug recovery from the meconium matrix.
- Only 57% of screen-positive meconium specimens were confirmed positive by GC-MS, indicating a potential false-positive rate of up to 43%.
Conclusions:
- Current drug extraction methods for meconium are not consistently efficient.
- Unconfirmed screening tests for drugs in meconium exhibit a high false-positive rate, necessitating confirmatory testing.